Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PDCD1, CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 AND Diagnosis
42 results:

  • 1. Exploring the clinical significance of IL-38 correlation with pd-1, CTLA-4, and FOXP3 in colorectal cancer draining lymph nodes.
    Yuan L; Tan Z; Huang J; Chen F; Hambly BD; Bao S; Tao K
    Front Immunol; 2024; 15():1384548. PubMed ID: 38533512
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours.
    Chen Y; Gao Z; Mohd-Ibrahim I; Yang H; Wu L; Fu Y; Deng Y
    Clin Transl Med; 2024 Feb; 14(2):e1543. PubMed ID: 38303608
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Multi-omics of the gut microbial ecosystem in patients with microsatellite-instability-high gastrointestinal cancer resistant to immunotherapy.
    Cheng S; Han Z; Dai D; Li F; Zhang X; Lu M; Lu Z; Wang X; Zhou J; Li J; Guo X; Song P; Qiu C; Shen W; Zhang Q; Zhu N; Wang X; Tan Y; Kou Y; Yin X; Shen L; Peng Z
    Cell Rep Med; 2024 Jan; 5(1):101355. PubMed ID: 38194971
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Case report: hepatic arterial infusion chemotherapy combined with sintilimab and lenvatinib for conversion therapy of colorectal cancer liver metastases.
    Peng K; Li Y; Su H; Lan C; Huang Z; Wei Y; Liao X; Peng M; Peng T; Zhu G
    Front Immunol; 2023; 14():1325445. PubMed ID: 38173715
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Sarcoma in patients with Lynch syndrome and response to immunotherapy.
    Shehata MS; Lofftus SY; Park JY; Singh AS; Federman NC; Eilber FC; Crompton JG; McCaw TR
    J Surg Oncol; 2024 Mar; 129(4):820-826. PubMed ID: 38151827
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CHSY1 promotes CD8
    Sun G; Zhao S; Fan Z; Wang Y; Liu H; Cao H; Sun G; Huang T; Cai H; Pan H; Rong D; Gao Y; Tang W
    J Exp Clin Cancer Res; 2023 Sep; 42(1):248. PubMed ID: 37749638
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition.
    Mishima S; Naito Y; Akagi K; Hayashi N; Hirasawa A; Hishiki T; Igarashi A; Ikeda M; Kadowaki S; Kajiyama H; Kato M; Kenmotsu H; Kodera Y; Komine K; Koyama T; Maeda O; Miyachi M; Nishihara H; Nishiyama H; Ohga S; Okamoto W; Oki E; Ono S; Sanada M; Sekine I; Takano T; Tao K; Terashima K; Tsuchihara K; Yatabe Y; Yoshino T; Baba E
    Int J Clin Oncol; 2023 Oct; 28(10):1237-1258. PubMed ID: 37599324
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Microsatellite Instability and Immune Response: From Microenvironment Features to Therapeutic Actionability-Lessons from colorectal cancer.
    Greco L; Rubbino F; Dal Buono A; Laghi L
    Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372349
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Pathological complete response after neoadjuvant immunotherapy combined with chemotherapy in pediatric rectal carcinoma: A case report.
    Cao X; Luo J; Zhao B; Fu H; Kang W
    Front Immunol; 2022; 13():1036181. PubMed ID: 36544760
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Tumor-derived extracellular vesicles in the colorectal cancer immune environment and immunotherapy.
    Prakash A; Gates T; Zhao X; Wangmo D; Subramanian S
    Pharmacol Ther; 2023 Jan; 241():108332. PubMed ID: 36526013
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Case report: Camrelizumab associated with central retinal vein occlusion.
    Zhan Y; Zhao W; Ni K; Liu Z; Su Y; Li X; Zhang H; Zhang C
    Front Immunol; 2022; 13():1025125. PubMed ID: 36505454
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Microsatellite instability/mismatch repair deficiency and activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland: A case report.
    Yang G
    Medicine (Baltimore); 2022 Aug; 101(34):e30311. PubMed ID: 36042639
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Roles of circulating tumor DNA in pd-1/PD-L1 immune checkpoint Inhibitors: Current evidence and future directions.
    Liu Z; Han Y; Dang Q; Xu H; Zhang Y; Duo M; Lv J; Li H; Kong Y; Han X
    Int Immunopharmacol; 2022 Oct; 111():109173. PubMed ID: 35998502
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. colorectal cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting.
    Aristin Revilla S; Kranenburg O; Coffer PJ
    Front Immunol; 2022; 13():903564. PubMed ID: 35874729
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Keratoacanthoma or cutaneous squamous cell carcinoma revealing a DNA mismatch repair default (Muir-Torre Syndrome).
    Miao Y; Kolb F; Tomasic G; Lupu J; Routier E; Robert C
    J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1():74-76. PubMed ID: 34855250
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Programmed cell death protein-1 inhibitors in the treatment of digestive system tumors in Chinese population: an observational study of effectiveness and safety.
    Yang W; Chang L; Guo Q; Chen J; Yu W; Zhang W
    Ann Palliat Med; 2021 Aug; 10(8):9015-9024. PubMed ID: 34488388
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. MSI testing : What's new? What should be considered?
    Rüschoff J; Baretton G; Bläker H; Dietmaier W; Dietel M; Hartmann A; Horn LC; Jöhrens K; Kirchner T; Knüchel R; Mayr D; Merkelbach-Bruse S; Schildhaus HU; Schirmacher P; Tiemann M; Tiemann K; Weichert W; Büttner R
    Pathologe; 2021 Nov; 42(Suppl 1):110-118. PubMed ID: 34477921
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Immune cell infiltration-associated signature in colon cancer and its prognostic implications.
    Deng D; Luo X; Zhang S; Xu Z
    Aging (Albany NY); 2021 Aug; 13(15):19696-19709. PubMed ID: 34349038
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [MSI testing : What is new? What should be considered? German version].
    Rüschoff J; Baretton G; Bläker H; Dietmaier W; Dietel M; Hartmann A; Horn LC; Jöhrens K; Kirchner T; Knüchel R; Mayr D; Merkelbach-Bruse S; Schildhaus HU; Schirmacher P; Tiemann M; Tiemann K; Weichert W; Büttner R
    Pathologe; 2021 Jul; 42(4):414-423. PubMed ID: 34043067
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2.
    Au L; Fendler A; Shepherd STC; Rzeniewicz K; Cerrone M; Byrne F; Carlyle E; Edmonds K; Del Rosario L; Shon J; Haynes WA; Ward B; Shum B; Gordon W; Gerard CL; Xie W; Joharatnam-Hogan N; Young K; Pickering L; Furness AJS; Larkin J; Harvey R; Kassiotis G; Gandhi S; ; Swanton C; Fribbens C; Wilkinson KA; Wilkinson RJ; Lau DK; Banerjee S; Starling N; Chau I; ; Turajlic S
    Nat Med; 2021 Aug; 27(8):1362-1366. PubMed ID: 34040262
    [TBL] [Abstract] [Full Text] [Related]  


    of 3.